BioSig Technologies, Inc Stock News

BioSig's (BSGM) subscription model for PURE EP provides electrophysiologists and cardiology departments with flexibility.

BioSig Technologies (NASDAQ: BSGM ) stock is rising higher on Thursday as subsidiary BioSig AI Sciences joins Nvidia's (NASDAQ: NVDA ) Inception program. The Inception program is one that Nvidia uses

The foundation of BioSig's (BSGM) AI medical device platform is set to be built upon integrated healthcare datasets.

Why investing in penny stocks in the long term could be the right choice The post The Benefits of Investing in Penny Stocks in the Long Term  appeared first on Penny Stocks to Buy, Picks, News and In

Penny stocks under $1 to watch before next week. The post 4 Hot Penny Stocks To Buy For Under $1 Before Next Week appeared first on Penny Stocks to Buy, Picks, News and Information | PennyStocks.com.

Here we discuss ShockWave Medical (SWAV), CheckCap (CHEK) and Biosig Technologies (BSGM) that have the potential to outperform their industry going forward.

The Dow Jones closed higher by more than 400 points on Wednesday. Investors, meanwhile, focused on some notable insider trades.

U.S. stocks recorded losses for the fourth straight session on Wednesday. Investors, meanwhile, focused on some notable insider trades.

BioSig Technologies Inc has announced that Kansas City Heart Institute at Overland Park Regional Medical Center in Kansas City, USA, has signed a purchase agreement to acquire its PURE EP System. Foll

BioSig Technologies Inc has earned a reiterated ‘Outperform' rating and $4 price target from analysts at Noble Capital days after pricing a public offering that generated proceeds of $2.9 million. 

BioSig Technologies, Inc. (NASDAQ:BSGM) has said it intends to offer shares of its common stock in a "best efforts" underwritten public offering. BioSig said it intends to use the net proceeds from th

BioSig Technologies, Inc. (NASDAQ:BSGM) said it has entered into an evaluation agreement for its PURE EP System with Cleveland Clinic, its first following the induction of a new commercialization tea

Despite numerous positive updates around its PURE EP segment, the market is agnostic in directional movements on the chart. Whilst the muddy waters on its PURE EP economics have been somewhat cleared,

BioSig Technologies Inc plans to kick off a national commercial launch campaign for its PURE EP System on July 1, 2022 following multiple initiatives to accelerate its transition from limited mark

BioSig Technologies Inc drew an ‘Outperform' rating from Noble Capital, which noted that "stronger commercialization efforts” are underway for the company's PURE (Precise Uninterrupted Real-time